Shanghai Yizhong Pharmaceutical Hits Day High with Strong 3.74% Surge

Shanghai Yizhong Pharmaceutical Co., Ltd. has experienced a notable increase of 3.74% on May 25, 2026, reaching an intraday high of CNY 59.40. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 0.96% on the same day. Over the past month, Shanghai Yizhong has shown a positive trend with a 7.56% increase, significantly outperforming the composite index's 1.78% gain. However, the stock has faced challenges in the longer term, with a decline of 9.24% over the past week and a substantial drop of 24.16% over the last three years. Despite these fluctuations, the company has demonstrated a strong annual growth rate in net sales of 196.91% and an operating profit growth of 48.07% over the last five years. However, it has reported negative results for the last five consecutive quarters, indicating potential concerns regarding its financial stability. The current market capitalization stands at CNY 13,104 million, with a price-to-earnings ratio of 173.00, reflecting a high valuation relative to its earnings.